Why Geron Corporation Stock Is Down a Shocking 52% in 2014
The FDA's clinical hold on imetelstat has rocked Geron's shares this year.
3 Longtime Losers About to See Green?
These 3 biotechs have lost tons of money every year so far in the 21st century. But could profits be on the horizon?
Better Buy: Dynavax Technologies Corp. vs. Geron Corp.
Dynavax Technologies Corp. and Geron Corp. have pending catalysts that could cause their shares to double from current levels. Here's a Foolish look at which company offers the better risk-to-reward profile.